Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/14/1997 | US5677143 Isolated nucleic acid encoding amino acid sequence of cellular protein |
10/14/1997 | US5677141 Process for producing 7-aminocephem compound or salts thereof |
10/14/1997 | US5677136 Using stem cell marker |
10/14/1997 | US5677131 System to detect protein-RNA interactions |
10/14/1997 | US5677126 Bonding to nucleic acid |
10/14/1997 | US5677124 Nucleic acid encapsulated by bacteriophage protein |
10/14/1997 | US5676985 Antifreeze polypeptide-expressing microorganisms useful in fermentation and freezing of foods |
10/14/1997 | US5676978 Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent |
10/14/1997 | US5676958 Use of aromatic aldehydes as insecticides and for killing arachnids |
10/14/1997 | US5676952 Genetic engineered vaccine |
10/14/1997 | US5676951 Bovine herpesvirus type 1 deletion mutants and vaccines |
10/14/1997 | US5676950 Enterically administered recombinant poxvirus vaccines |
10/14/1997 | US5676946 Phospholipase C homolog |
10/14/1997 | US5676945 Antitumor agent |
10/14/1997 | US5676943 Nerve growth factor |
10/14/1997 | US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor |
10/14/1997 | US5676646 For implanting molecules into living blood cells |
10/14/1997 | CA1339493C Genetic identification employing dna probes of variable number tandem r epeat loci |
10/13/1997 | CA2174040A1 Gene therapy for myocardial ischemia |
10/10/1997 | CA2190812A1 Polypeptide |
10/09/1997 | WO1997037230A1 Tfiib transcription factor from candida albicans |
10/09/1997 | WO1997037228A1 Methods for diagnosing and treating alzheimer's disease |
10/09/1997 | WO1997037225A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+-DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
10/09/1997 | WO1997037223A1 Identification and isolation of novel polypeptides having ww domains and methods of using same |
10/09/1997 | WO1997037220A1 Compositions and methods for screening drug libraries |
10/09/1997 | WO1997037045A1 Improved technique for differential display |
10/09/1997 | WO1997037044A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
10/09/1997 | WO1997037043A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
10/09/1997 | WO1997037039A2 Use of extremely thermophilic dna-polymerases |
10/09/1997 | WO1997037037A1 Phosphatase modulator |
10/09/1997 | WO1997037033A1 Novel plant enzyme and use thereof |
10/09/1997 | WO1997037031A1 Parapoxvirus vectors |
10/09/1997 | WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein |
10/09/1997 | WO1997037027A1 Novel cyclin-selective ubiquitin carrier polypeptides |
10/09/1997 | WO1997037026A1 Novel compounds |
10/09/1997 | WO1997037025A1 Surface anchoring vector and system for foreign proteins thereof |
10/09/1997 | WO1997037024A2 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
10/09/1997 | WO1997037023A1 Fruit ripening |
10/09/1997 | WO1997037022A1 Human natural killer cell activating factor ii |
10/09/1997 | WO1997037021A1 Human cystatin f |
10/09/1997 | WO1997037020A1 Apo-2li and apo-3 apoptosis polypeptides |
10/09/1997 | WO1997037019A1 Cell proliferation inhibitor |
10/09/1997 | WO1997037018A1 Novel gene |
10/09/1997 | WO1997037017A1 Cytostatic factors |
10/09/1997 | WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
10/09/1997 | WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
10/09/1997 | WO1997037014A1 Genetic suppression and replacement |
10/09/1997 | WO1997037013A1 Asymmetric hammerhead ribozymes |
10/09/1997 | WO1997037012A1 Single-step excision means |
10/09/1997 | WO1997037011A1 Meiotic recombination in vivo of partially homologous dna sequences |
10/09/1997 | WO1997037010A1 Active survival domains of igf-ir and methods of use |
10/09/1997 | WO1997037009A1 Cultured inner cell mass cell lines derived from ungulate embryos |
10/09/1997 | WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells |
10/09/1997 | WO1997036998A1 Genes of carotenoid biosynthesis and metabolism and a system for screening for such genes |
10/09/1997 | WO1997036960A1 Asymmetric benzoxanthene dyes |
10/09/1997 | WO1997036929A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
10/09/1997 | WO1997036928A1 Monoclonal antibody that detects apoptotic antigen |
10/09/1997 | WO1997036926A1 Growth differentiation factor-14 |
10/09/1997 | WO1997036925A1 Candida albicans tata-binding protein, nucleic acid and assays |
10/09/1997 | WO1997036924A1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
10/09/1997 | WO1997036923A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
10/09/1997 | WO1997036919A2 Cytokine designated lerk-8 |
10/09/1997 | WO1997036917A1 Chitotriosidase |
10/09/1997 | WO1997036914A1 High molecular weight surface proteins of non-typeable haemophilus |
10/09/1997 | WO1997036681A1 Device and method for multiple analyte detection |
10/09/1997 | WO1997036618A1 Diagnostic composition for diseases accompanied by autoimmune reactions caused by 65k-glutamic acid decarboxylase |
10/09/1997 | WO1997036613A1 Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
10/09/1997 | WO1997036601A1 Cyclic peptide vaccines for treatment and prevention of diabetes |
10/09/1997 | WO1997036481A1 Design of novel highly efficient hiv based packaging systems for gene therapy |
10/09/1997 | WO1997036477A1 Transgenic model of heart failure |
10/09/1997 | WO1997032022A3 Canine ob protein compositions and methods |
10/09/1997 | WO1997032018A3 Hepatitis c virus ribozymes |
10/09/1997 | WO1997031115A3 Synthetic hiv genes |
10/09/1997 | WO1997030165A3 Method for the induction of genetic parthenocarpy in plants |
10/09/1997 | WO1997030156A3 Nucleotides and peptides corresponding to the canine ige heavy chain constant region and related methods |
10/09/1997 | WO1997030150A3 Molecules for the induction of immunological tolerance |
10/09/1997 | WO1997029210A3 Fluorescence detection assay for homogeneous pcr hybridization systems |
10/09/1997 | WO1997029123A3 Nucleic acid encoding gai gene of arabidopsis thaliana |
10/09/1997 | WO1997028279A3 Positive controls for use in polynucleotide amplification |
10/09/1997 | WO1997028247A3 AMINO ACID-ENRICHED PLANT PROTEIN RESERVES, PARTICULARLY LYSINE-ENRICHED MAIZE η-ZEIN, AND PLANTS EXPRESSING SUCH PROTEINS |
10/09/1997 | WO1997026363A3 Method of inducing nitrogen fixation in plants |
10/09/1997 | WO1997026330A3 Morphological mutants of filamentous fungi |
10/09/1997 | WO1997023599A3 A method for regulation of plant lignin composition |
10/09/1997 | WO1997023597A3 Process for the microbial production of amino acids by boosted activity of export carriers |
10/09/1997 | WO1997021820A3 A novel protein kinase required for ras signal transduction |
10/09/1997 | WO1997017447A3 Plant vde genes and methods related thereto |
10/09/1997 | DE19613406A1 Expression von HGV-Antigenen und deren Verwendung Expression of HGV antigens and their use |
10/09/1997 | CA2259133A1 High molecular weight surface proteins of non-typeable haemophilus |
10/09/1997 | CA2250870A1 Compositions and methods for screening drug libraries |
10/09/1997 | CA2250866A1 Identification and isolation of novel polypeptides having ww domains and methods of using same |
10/09/1997 | CA2250857A1 Asymmetric hammerhead ribozymes |
10/09/1997 | CA2250849A1 Novel cyclin-selective ubiquitin carrier polypeptides |
10/09/1997 | CA2250834A1 Cultured inner cell mass cell lines derived from ungulate embryos |
10/09/1997 | CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells |
10/09/1997 | CA2250814A1 Cyclic peptide vaccines for treatment and prevention of diabetes |
10/09/1997 | CA2250702A1 Active survival domains of igf-ir and methods of use |
10/09/1997 | CA2250269A1 Human natural killer cell activating factor ii |
10/09/1997 | CA2250129A1 Candida albicans tata-binding protein, nucleic acid and assays |
10/09/1997 | CA2250121A1 Tfiib transcription factor from candida albicans |
10/09/1997 | CA2250111A1 Single-step excision means |